Quarterly report pursuant to Section 13 or 15(d)

Clinical Trial and Sponsored Research Agreements (Sponsored Research and Clinical Trial Agreements) (Details)

v3.22.2.2
Clinical Trial and Sponsored Research Agreements (Sponsored Research and Clinical Trial Agreements) (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]        
Research and development expense $ 15,419 $ 14,083 $ 46,872 $ 36,603
Sponsored Research and Clinical Trial Agreements [Member]        
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]        
Research and development expense 1,836 1,756 4,884 4,858
City of Hope National Medical Center ("COH") [Member] | Sponsored Research and Clinical Trial Agreements [Member]        
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]        
Research and development expense 0 0 0 0
Mayo Clinic [Member] | Sponsored Research and Clinical Trial Agreements [Member]        
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]        
Research and development expense 269 231 731 464
CD123 (MB-102) [Member] | City of Hope National Medical Center ("COH") [Member] | Sponsored Research and Clinical Trial Agreements [Member]        
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]        
Research and development expense 62 24 165 250
IL13Ra2 (MB-101) [Member] | City of Hope National Medical Center ("COH") [Member] | Sponsored Research and Clinical Trial Agreements [Member]        
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]        
Research and development expense 192 199 654 992
CS1 (MB-104) [Member] | City of Hope National Medical Center ("COH") [Member] | Sponsored Research and Clinical Trial Agreements [Member]        
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]        
Research and development expense 187 138 287 510
HER2 (MB 103) [Member] | City of Hope National Medical Center ("COH") [Member] | Sponsored Research and Clinical Trial Agreements [Member]        
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]        
Research and development expense 691 319 1,233 473
PSCA (MB-105) [Member] | City of Hope National Medical Center ("COH") [Member] | Sponsored Research and Clinical Trial Agreements [Member]        
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]        
Research and development expense 27   77 69
Research and Development (Income) Expenses   23    
CD20 (MB-106) [Member] | Fred Hutchinson Cancer Center [Member] | Sponsored Research and Clinical Trial Agreements [Member]        
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]        
Research and development expense 132 492 978 1,490
ST. Jude - XSCID [Member] | St. Jude Children's Research Hospital [Member] | Sponsored Research and Clinical Trial Agreements [Member]        
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]        
Research and development expense 184 330 402 610
RAG1 SCID (MB-110) [Member] | Leiden University Medical Centre [Member] | Sponsored Research and Clinical Trial Agreements [Member]        
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]        
Research and development expense $ 92 $ 0 $ 357 $ 0